C2I: 9-[(1R,6R,8R,9S,10R,15S,17R,18S)-3,9,12,18-tetrakis(oxidanyl)-3,12-bis(oxidanylidene)-17-(6-oxidanylidene-3H-purin-9-yl)-2,4,7,11,13,16-hexaoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.3.0.0^{6,10}]octadecan-8-yl]-3H-purin-6-one
C2I is a Ligand Of Interest in 6K6T designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6K6T_C2I_A_501 | 72% | 2% | 0.131 | 0.956 | 5.57 | 1.71 | 20 | 9 | 2 | 0 | 100% | 1 |
| 6K6T_C2I_C_501 | 69% | 1% | 0.134 | 0.95 | 5.69 | 1.87 | 20 | 13 | 1 | 0 | 100% | 1 |
| 6K6T_C2I_B_501 | 66% | 1% | 0.138 | 0.945 | 5.66 | 1.89 | 19 | 15 | 0 | 0 | 100% | 1 |
| 6K6T_C2I_D_501 | 65% | 2% | 0.147 | 0.95 | 5.71 | 1.55 | 20 | 10 | 3 | 0 | 100% | 1 |
